
Volcanics Venture
Description
Volcanics Venture, established in 2016 by veteran investor Zhang Jun, is a prominent venture capital firm based in Shanghai, China. The firm primarily focuses on capital investments in early and growth-stage companies, with a strategic emphasis on two core sectors: internet innovation (encompassing TMT) and healthcare. Their investment philosophy is rooted in identifying disruptive technologies and business models that have the potential for significant market impact within the Chinese landscape. Volcanics Venture aims to partner with ambitious entrepreneurs, providing not just capital but also strategic guidance and operational support to foster sustainable growth.
The firm has successfully raised substantial capital across multiple funds, demonstrating strong investor confidence. For instance, their third USD fund successfully closed at $300 million in 2021, underscoring their capacity to deploy significant capital into promising ventures. Volcanics Venture typically targets companies in their Series A to Series C funding rounds, indicating a preference for businesses that have moved beyond the seed stage but still possess considerable growth runway. Their approach involves deep industry research and a hands-on engagement model, aiming to add value beyond mere financial injection.
Volcanics Venture's typical first cheque sizes range from approximately $5 million to $25 million, reflecting their commitment to providing meaningful capital injections for their target stages. This range allows them to support a diverse portfolio of companies, from those just beginning to scale to more established growth-stage enterprises. The firm's track record includes early investments in several now-prominent technology companies, showcasing their acumen in identifying future market leaders. Their long-term vision and commitment to fostering innovation position them as a key player in China's dynamic venture capital ecosystem.
Investor Profile
Volcanics Venture has backed more than 22 startups, with 2 new investments in the last 12 months alone. The firm has led 3 rounds, about 14% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Angel rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
- Typical check size: $5M – $25M.
Stage Focus
- Series A (50%)
- Series B (27%)
- Angel (9%)
- Seed (9%)
- Series C (5%)
Country Focus
- China (73%)
- United States (27%)
Industry Focus
- Biotechnology
- Health Care
- Artificial Intelligence (Ai)
- Biopharma
- Precision Medicine
- Software
- Robotics
- Medical Device
- Manufacturing
- Automotive
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.